The same genome, read eight different ways. This dataset reveals how genetic variants alter gene expression in neurons, glia, and vascular cells — exposing the cell-type-specific wiring behind psychiatric and neurological disease.
Every cell in the human brain carries the same DNA. Yet an excitatory neuron firing in the prefrontal cortex and a microglia patrolling for pathogens in the white matter behave as though they are reading entirely different instruction manuals. The difference lies not in the genome itself but in how each cell type regulates which genes are expressed, when, and at what level. Expression quantitative trait loci — eQTLs — are the genetic variants that modulate this regulation, and until recently, brain eQTL studies treated the organ as a single homogeneous tissue, averaging across dozens of distinct cell populations.
Bryois and colleagues changed that. By mapping cis-eQTLs separately in eight major brain cell types — excitatory neurons, inhibitory neurons, astrocytes, oligodendrocytes, OPCs, microglia, endothelial cells, and pericytes — they revealed that a substantial fraction of genetic regulation is invisible in bulk tissue analyses. A variant that strongly upregulates a gene in microglia may have no detectable effect in neurons, and vice versa. This cell-type specificity is not an edge case; it is the rule. The majority of eQTLs identified in this dataset show significant effects in only one or two of the eight cell types tested.
The implications for disease genetics are profound. Genome-wide association studies (GWAS) have identified hundreds of risk loci for schizophrenia, Alzheimer's disease, and other brain disorders, but most fall in non-coding regions whose functional targets are unknown. By overlaying GWAS signals onto cell-type-specific eQTL maps, researchers can now ask: in which cell type does this risk variant actually alter gene expression? The answer frequently points to unexpected cell populations — Alzheimer's risk variants enriched in microglial eQTLs, schizophrenia variants concentrated in neuronal regulatory circuits. With 406,000 downloads, this dataset has become a standard reference for anyone connecting genetic risk to cellular mechanism in the brain.
Number of significant cis-eQTL associations (FDR < 0.05) identified in each of the eight brain cell types
Proportion of eQTLs by how many cell types they reach significance in — most are specific to one or two cell types
Cell-type-specific eQTL maps allow GWAS risk loci for schizophrenia, bipolar disorder, and depression to be resolved to the specific brain cell population where the variant exerts its regulatory effect.
The enrichment of Alzheimer's risk variants in microglial eQTLs strengthens the case for immune-mediated neurodegeneration and suggests therapeutic targets in innate immunity rather than neurons alone.
Knowing which cell type a genetic variant acts through enables cell-type-targeted drug design, reducing off-target effects by focusing on the precise cellular context of disease mechanisms.
Share this story